Since the advent of
PSA screening, the incidence of patients presenting with advanced prostate cancer has
declined remarkably and death
rates from prostate cancer as reported in the National Cancer Database have
declined at the
rate of 1 % per year since 1990.56 Other data indicate similar
declines in prostate cancer related mortality in the US.